Panduan definitif tentang penyuntingan gen.
Menu
Beranda Pelajari Berita Tanya Atlas
Jelajahi Teknologi Penyakit Perawatan Uji Klinis Perusahaan Ilmuwan Gen-gen Penelitian Institusi
Di luar dunia medis Pertanian Etika Investasi Peta dunia
Pelajari & Alat Mulai di sini Glosarium A–Z Bandingkan teknologi Linimasa Daftar & Peringkat Agen AI ★ Tersimpan API
Tentang Tentang kami Metodologi Sumber Data Kebijakan Editorial Kontak Penafian

🧭 Tampilan Terpandu
Baru mengenal genetika? Kami menjelaskan setiap istilah saat kamu menjelajah, dalam bahasa yang mudah dipahami. Halaman yang sama, dengan bantuan yang sudah tersedia.

⚡ Pandangan Ahli
Kamu sudah mengenal biologinya. Cukup kontennya — ringkas dan padat, tanpa penjelasan tambahan. Ini adalah tampilan default.

Bahasa antarmuka
Mode terang

Diseases

Diseases in Gene-Editing Clinical Trials

Conditions where gene editing is being tested in people, as distinct from being discussed.

Bagaimana daftar ini dibuat

These are conditions where editing has reached actual patients in registered trials. It is a much longer list than the approved one and a much shorter list than the diseases people expect CRISPR to solve.

#EntriKategori Status
1 Sickle Cell Disease An inherited blood disorder in which a single DNA letter change makes red blood cells… Blood disorders Approved
2 Beta Thalassemia An inherited disorder in which the body makes too little beta-globin, leaving many… Blood disorders Approved
3 ATTR Amyloidosis A disease in which a misfolded liver protein accumulates in the heart and nerves — and… Metabolic disease Phase III
4 Hereditary Angioedema A rare disorder causing sudden, unpredictable and sometimes life-threatening swelling… Rare genetic disease Phase III
5 High Cholesterol and Familial Hypercholesterolemia The most common cause of premature heart disease, and the first attempt to treat an… Cardiovascular disease Phase II
6 Cancer Not one disease but hundreds — and the place where gene editing is used to engineer… Cancer Phase II
7 Leukemia and Lymphoma Blood cancers, where engineered cell therapy has worked best — and where the first… Cancer Phase II
8 HIV A virus that hides inside the genome of the cells it infects — which is why editing has… Infectious disease Phase I
9 Duchenne Muscular Dystrophy A severe muscle-wasting disease caused by mutations in the largest gene in the human… Muscular disease Preclinical
10 Cystic Fibrosis A disease of thick mucus in the lungs and gut where highly effective drugs already exist… Rare genetic disease Preclinical
11 Hemophilia An inherited bleeding disorder in which gene addition reached approval first, leaving… Blood disorders Preclinical
12 Inherited Blindness Inherited retinal disease was where in vivo CRISPR was first injected directly into a… Eye disease Phase I/II
13 Alpha-1 Antitrypsin Deficiency A single-letter mutation that damages the lungs by absence and the liver by accumulation… Rare genetic disease Phase III
14 Chronic Granulomatous Disease A rare immune disorder in which white blood cells cannot kill the bacteria they engulf —… Rare genetic disease Phase I/II
15 Huntington's Disease A fatal inherited brain disease caused by a toxic protein — where the genetics are… Neurological disease Preclinical
16 Parkinson's Disease A common neurodegenerative disease that is mostly not genetic — which makes it a poor fit… Neurological disease Discovery
17 Alzheimer's Disease The most common cause of dementia, where a well-known risk gene exists but editing… Neurological disease Discovery
18 Diabetes Where editing is being used not to correct a gene but to hide transplanted… Metabolic disease Phase I
19 Retinitis Pigmentosa A group of inherited retinal degenerations with over 80 causative genes — where the… Eye disease Preclinical
Apa yang tidak diberitahu daftar ini kepadamuInclusion means research is happening, not that a treatment works or is available. Each disease page states its evidence level.
Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026